8-143215394-C-T
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PS1_ModerateBP4_StrongBP6_Very_StrongBA1
The NM_178172.6(GPIHBP1):c.431C>T(p.Ser144Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0089 in 1,612,860 control chromosomes in the GnomAD database, including 972 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
NM_178172.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPIHBP1 | NM_178172.6 | c.431C>T | p.Ser144Phe | missense_variant | 4/4 | ENST00000622500.2 | NP_835466.2 | |
GPIHBP1 | NM_001301772.2 | c.375+56C>T | intron_variant | NP_001288701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPIHBP1 | ENST00000622500.2 | c.431C>T | p.Ser144Phe | missense_variant | 4/4 | 1 | NM_178172.6 | ENSP00000480053.1 |
Frequencies
GnomAD3 genomes AF: 0.0457 AC: 6955AN: 152190Hom.: 509 Cov.: 34
GnomAD3 exomes AF: 0.0127 AC: 3158AN: 249206Hom.: 214 AF XY: 0.00938 AC XY: 1269AN XY: 135262
GnomAD4 exome AF: 0.00506 AC: 7396AN: 1460554Hom.: 464 Cov.: 35 AF XY: 0.00437 AC XY: 3173AN XY: 726562
GnomAD4 genome AF: 0.0457 AC: 6959AN: 152306Hom.: 508 Cov.: 34 AF XY: 0.0433 AC XY: 3227AN XY: 74482
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 16, 2019 | This variant is associated with the following publications: (PMID: 32041611, 22239554) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
GPIHBP1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 29, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at